Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
01/03/1996 | EP0689459A1 Novel agent for controlling cell activity |
01/03/1996 | EP0689453A1 High molecular weight surface proteins of non-typeable haemophilus |
01/03/1996 | EP0689447A1 Cytopathic viruses for therapy and prophylaxis of neoplasia |
01/03/1996 | EP0689433A1 Novel metal binding agents, and methods and compositions for their use to treat metal toxicity |
01/03/1996 | EP0689421A1 Reduced and controlled surface binding of biologically active molecules |
01/03/1996 | EP0626012A4 Homogenotization of gene-targeting events. |
01/03/1996 | EP0580685B1 Pharmaceutical packaging unit containing plasminogen activators for multiple-bolus administration |
01/03/1996 | EP0498851B1 Urinary tumor associated antigen, antigenic subunits uses and methods of detection |
01/03/1996 | EP0478602B1 Expression of tetanus toxin fragment c |
01/03/1996 | EP0473701B1 Recombinant dna method for production of parathyroid hormone |
01/03/1996 | EP0458971B1 Inosine guanosine kinase |
01/03/1996 | EP0275300B1 Recombinant vaccine |
01/03/1996 | CN1114359A Homogenous method for assay of double-stranded nucleic acids using fluorescent dyes and kit useful therein |
01/03/1996 | CN1114357A Process for producing recombinative polypeptide using transgene animal |
01/03/1996 | CN1114356A An enzyme with endoglucanase activity |
01/03/1996 | CN1114355A DNA amplification |
01/03/1996 | CN1114196A Process for producing human blood protein with mammal |
01/02/1996 | US5480981 Hodgkin's disease |
01/02/1996 | US5480972 Diagnosing, treating and preventing sensitivity; dna sequences |
01/02/1996 | US5480968 Isolated polypeptide erbB-3, related to the epidermal growth factor receptor and antibody thereto |
01/02/1996 | US5480956 Feline interferon and process for production thereof |
01/02/1996 | US5480895 Method of producing antibodies to a restricted population of T lymphocytes, antibodies produced therefrom and methods of use thereof |
01/02/1996 | US5480864 Modified maxadilan fusion protein containing a thrombin cleavage site; composition for topical application to mammals' skin comprises modified maxadilan protein as vasodilator in vehicle |
01/02/1996 | US5480805 Composition for modulating sterols in yeast |
01/02/1996 | US5480801 Purified PH neutral Rhizoctonia laccases and nucleic acids encoding same |
01/02/1996 | US5480800 Strain carrying plasmid permitting production of recombinant enzyme that fragments n-acetylheparosan, strain obtained by transforming strain rri of escherichia coli/k12/ or equivalent strain with vector carrying the dna fragment; plasmid p868,26 |
01/02/1996 | US5480799 Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope |
01/02/1996 | US5480798 Baker's yeast having a low temperature inactivation property |
01/02/1996 | US5480797 Augmenter of liver regeneration (ALR) |
01/02/1996 | US5480796 Antibodies against the receptor protein for human B cell stimulatory factor-2 |
01/02/1996 | US5480795 Curculin B and DNA encoding same, and process for production thereof |
01/02/1996 | US5480794 Polyhydroxyalkanoate polymerases |
01/02/1996 | US5480793 Nucleic acid coding for the human angiotensin converting enzyme (ACE), and its uses, especially for the in vitro diagnosis of arterial hypertension |
01/02/1996 | US5480789 Genetically transformed rose plants and methods for their production |
01/02/1996 | US5480784 Nucleic acid sequence amplification methods |
01/02/1996 | US5480783 Method for reducing background signals in DNA replication/detection assays |
01/02/1996 | US5480772 Separation of nucleus from erythrocytes using protease and nonionic detergents, contacting with cytostatic factor extract and pretreatment with activating egg extract |
01/02/1996 | CA2150532A1 Polypeptides |
12/30/1995 | CA2152233A1 Oligonucleotides to inhibit the expression of isoprenyl protein transferases |
12/28/1995 | WO1995035505A1 Method and apparatus for fabricating microarrays of biological samples |
12/28/1995 | WO1995035389A1 Method for introduction of genetic material into microorganisms and transformants obtained therewith |
12/28/1995 | WO1995035388A1 Plant genetic transformation methods and transgenic plants |
12/28/1995 | WO1995035387A1 Regulated expression of heterologous genes in plants and transgenic fruit with a modified ripening phenotype |
12/28/1995 | WO1995035386A1 Expression control polynucleotides derived from spliceosomal protein gene promoters |
12/28/1995 | WO1995035385A1 A FUNGUS WHEREIN THE areA GENE HAS BEEN MODIFIED AND AN areA GENE FROM ASPERGILLUS ORYZAE |
12/28/1995 | WO1995035384A1 N-terminally extended proteins expressed in yeast |
12/28/1995 | WO1995035383A2 Plant genes affecting gibberellic acid biosynthesis |
12/28/1995 | WO1995035382A2 NOVEL AMYLOLYTIC ENZYMES DERIVED FROM THE B. LICHENIFORMIS α-AMYLASE, HAVING IMPROVED CHARACTERISTICS |
12/28/1995 | WO1995035381A1 Modified pseudomonas lipases and their use |
12/28/1995 | WO1995035380A1 Nucleotide sequences of pestivirus strains, polypeptides encoded by these sequences and use thereof for diagnosis and prevention of pestivirus infections |
12/28/1995 | WO1995035379A1 66 kDa ANTIGEN FROM BORRELIA |
12/28/1995 | WO1995035378A1 Novel bacillus thuringiensis strains active against lepidopteran and coleopteran pests |
12/28/1995 | WO1995035377A2 Materials and methods for detection of oxalate |
12/28/1995 | WO1995035376A2 Polypeptides with interleukin 8 receptor 1 (il8r1) binding domains |
12/28/1995 | WO1995035375A1 Interleukin-5 specific recombinant antibodies |
12/28/1995 | WO1995035374A1 Human monoclonal antibodies specific to cell cycle independent glioma surface antigen |
12/28/1995 | WO1995035373A2 Nucleic acid molecules encoding human contactin |
12/28/1995 | WO1995035372A1 5-lipoxygenase-activating protein ii |
12/28/1995 | WO1995035371A1 Glucan elicitor receptor and dna coding for the same |
12/28/1995 | WO1995035370A1 Schistosoma protein and uses thereof |
12/28/1995 | WO1995035369A1 METHODS AND COMPOSITIONS FOR cDNA SYNTHESIS |
12/28/1995 | WO1995035368A1 Extraction of heterologous insoluble proteins from bacteria |
12/28/1995 | WO1995035367A1 CRYSTAL STRUCTURE AND MUTANTS OF INTERLEUKIN-1β CONVERTING ENZYME |
12/28/1995 | WO1995035320A1 High-affinity melatonin receptors and uses thereof |
12/28/1995 | WO1995035318A1 Plant genes for sensitivity to ethylene and pathogens |
12/28/1995 | WO1995035118A1 Contraceptive vaccine |
12/28/1995 | WO1995035115A1 DNA ENCODING AN 18 Kd CDK6 INHIBITING PROTEIN |
12/28/1995 | WO1995035111A2 USE OF βGalNac(1-4)βGal CONJUGATES TO TREAT CANDIDA INFECTION |
12/28/1995 | WO1995035032A1 SUPPRESSION OF NUCLEAR FACTOR-kB DEPENDENT PROCESSES USING OLIGONUCLEOTIDES |
12/28/1995 | WO1995035027A1 Starch and grain with a novel genotype |
12/28/1995 | WO1995035026A1 Novel plants and processes for obtaining them |
12/28/1995 | WO1995035024A1 Plant virus resistance gene and methods |
12/28/1995 | WO1995033818A3 Genes for the synthesis of antipathogenic substances |
12/28/1995 | WO1995032286A3 Immunogenic carcinoembryonic antigen and methods of use and production |
12/28/1995 | WO1995030009A3 Identification, production and use of saponin glyclosyl hydrolases |
12/28/1995 | WO1995029260A3 Detection of fungal pathogens using the polymerase chain reaction |
12/28/1995 | WO1995028487A3 Recombinant pgp3, methods of preparation and use in diagnosis and therapy |
12/28/1995 | WO1995027495A3 Treatment of partial growth hormone insensitivity syndrome |
12/28/1995 | WO1995020664A3 Mammalian expression systems for hepatitis c virus envelope genes |
12/28/1995 | WO1995017512A3 Proteases from streptomyces and use thereof in protein expression systems |
12/28/1995 | WO1995016051A3 Methods and compositions for the suppression of neu mediated transformation |
12/28/1995 | WO1995015982A3 Process for generating specific antibodies |
12/28/1995 | CA2193674A1 Materials and methods for detection of oxalate |
12/28/1995 | CA2193625A1 Novel bacillus thuringiensis strains active against lepidopteran and coleopteran pests |
12/28/1995 | CA2193526A1 Polypeptides with interleukin 8 receptor 1 (il8r1) binding domains |
12/28/1995 | CA2193487A1 Methods and compositions for cdna synthesis |
12/28/1995 | CA2193255A1 Plant genes for sensitivity to ethylene and pathogens |
12/28/1995 | CA2193206A1 Contraceptive vaccine |
12/28/1995 | CA2193205A1 High-affinity melatonin receptors and uses thereof |
12/28/1995 | CA2193123A1 Plant virus resistance gene and methods |
12/28/1995 | CA2193084A1 Plant genes affecting gibberellic acid biosynthesis |
12/28/1995 | CA2192971A1 Expression control polynucleotides derived from spliceosomal protein gene promoters |
12/28/1995 | CA2192943A1 N-terminally extended proteins expressed in yeast |
12/28/1995 | CA2192827A1 Use of .beta.galnac(1-4).beta.gal conjugates to treat candida infection |
12/28/1995 | CA2192485A1 Crystal structure and mutants of interleukin-1.beta. converting enzyme |
12/28/1995 | CA2190761A1 Novel plants and processes for obtaining them |
12/28/1995 | CA2169739A1 Glucan elicitor receptor and dna coding for the same |
12/27/1995 | EP0689289A2 Transfection high-voltage controller |
12/27/1995 | EP0688874A2 Nucleic acid fragments and diagnostic reagents derived from the genome of HHV6/SIE and diagnostic procedures for HHV6 infections |
12/27/1995 | EP0688873A2 Fast DNA assay for the detection of chinolon resistant staphylococcus aureus in clinical material |